Author

T. Rivera-Hernandez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Cerbulo-Vazquez· 2 shared C. Lopez-Macias· 2 shared A. Garcia-Sastre· 1 shared A. J. Cork· 1 shared A. Suarez-Martinez· 1 shared A. Tepale-Segura· 1 shared A. Torres-Flores· 1 shared B. L. Schulz· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Cerbulo-Vazquez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated

A. Torres-Flores, L. A. Ontiveros-Padilla, R. L. Madera-Sandoval, A. Tepale-Segura, J. Gajon-Martinez, T. Rivera-Hernandez, E. A. Ferat-Osorio, A. Cerbulo-Vazquez, L. A. Arriaga-Pizano, L. Bonifaz, G. Paz-De la Rosa, O. Rojas-Martinez, A. Suarez-Martinez, G. Peralta-Sanchez, D. Sarfati-Mizrahi, , C. Lopez-Macias

This paper evaluates the AVX/COVID-12 vaccine's ability to activate T cells and bind antibodies from vaccinated individuals and SARS-CoV-2-infected patients.

bioRxiv · Mar 1, 2024 · PreprintImmunology

Bioinformatic analysis of shared B and T cell epitopes amongst relevant coronaviruses to human health: Is there cross-protection?

D. L. Pacheco-Olvera, S. Saint Remy-Hernandez, E. Acevedo-Ochoa, L. Arriaga-Pizano, A. Cerbulo-Vazquez, E. Ferat-Osorio, T. Rivera-Hernandez, C. Lopez-Macias

This study reviews shared B and T cell epitopes among SARS-CoV, MERS-CoV, and SARS-CoV-2 and predicts novel epitopes, suggesting cross-reactive T cell responses may contribute to immunity against SARS-CoV-2.

bioRxiv · Jul 14, 2020 · PreprintImmunology

Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes

S. Brouwer, T. C. Barnett, D. Ly, K. J. Kasper, D. M. De Oliveira, T. Rivera-Hernandez, A. J. Cork, L. McIntyre, M. G. Jespersen, J. Richter, B. L. Schulz, G. Dougan, V. Nizet, K.-Y. Yuen, Y. You, , M. J. Walker

This study identifies prophage-encoded exotoxins in Streptococcus pyogenes that enhance colonization fitness and pathogenesis in scarlet fever.

bioRxiv · May 17, 2020Microbiology